Overview
Urtica is a pharmaceutical wholesaler and nationwide medicine distributor serving hospitals, pharmacies, healthcare providers and pharmaceutical wholesalers. It supports manufacturers of generic and original medicines with market analysis, hospital tenders, sales, storage, distribution and communication with professional customers. The company also handles named-patient imports and logistics for products stored at temperatures from −150°C to +25°C, in line with Good Distribution Practice and ISO 9001:2015 requirements.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Urtica Adopted the Sustainable Development Strategy
Digitization in Pharmacy Begins with a Need
Targeted Import in Practice. Urtica's Free E-book
Safe Handling of Products under Special Supervision
PAA President's Permit for Urtica to Store Radioactive Sources and Waste
Two Years of e-Urtica: A Portal for Collaboration, Knowledge, and Development
Industry
Bank accounts
Registered as a VAT taxpayer on 1999-11-22. Active
28 1560 0013 2023 3861 8000 0003
04 1050 0086 1000 0090 8127 7775- 13 1050 0086 1000 0090 8051 1604
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 410.2KPLN 410,217 |
Public aid
5 public aid cases recorded, with a total value of $16,870.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 6, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,052$5,052 | Prezydent Miasta Katowice | |
| Aug 4, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,726$3,726 | Prezydent Wrocławia | |
| Jul 16, 2021 | Other crisis aid | $6,056$6,056 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
Tenders
6876 tenders recorded as contractor: 1895 national ($109,354,669) and 4981 EU ($20,673,920,362).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 15, 2026 | Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach | –– | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach | |
| Oct 15, 2026 | Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach | –– | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach | |
| Oct 15, 2026 | Dostawa leków dla spzzoz w Przasnyszu | –– | Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej |
Public sector contracts
Urtica is the contractor in 4172 public sector contracts, worth PLN 1.14bn in total. They were signed with 303 public buyers. The largest number (15) were signed with Zachodniopomorskie Centrum Onkologii.
| Public buyer | Value | |
|---|---|---|
| Wojewódzki Szpital Specjalistyczny Im. Św. Rafała w Czerwonej Górze | PLN 752.40 | |
| Szpital Specjalistyczny Im. Jędrzeja Śniadeckiego w Nowym Sączu | PLN 314,151 | |
| Wojewódzki Szpital Obserwacyjno-Zakaźny Im. Tadeusza Browicza | PLN 60.11 | |
| Podhalański Szpital Specjalistyczny Im. Jana Pawła II w Nowym Targu | PLN 53.00 | |
| Krakowski Szpital Specjalistyczny Im. Św. Jana Pawła II | PLN 10.60 |
Public procurement disputes (KIO)
Urtica has been a party to 20 cases before the National Appeal Chamber (since 2018). It filed 19 appeals (11 upheld, 2 dismissed, 5 discontinued, 1 rejected). In 1 case it joined the proceedings as a participant.
Trademarks
Urtica holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| urtica | Jan 23, 2037 | |
| PGF URTICA | – |
Authorized Representatives
Manner of representation
In the event that a multi-member management board is appointed, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required for the validity of declarations submitted on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 42,000 | $5,672,609.40 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
LideoS.A. | 1,550,193.95 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NeucaS.A. | $3,426,322,199.90 | inwestor.neuca.pl | ||
| Polska Grupa FarmaceutycznaS.A. | $1,767,903,566.05 | pgf.com.pl | ||
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| HurtapS.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| Onninensp. z o.o. | $410,385,925.20 | onninen.pl | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| Medi&Moresp. z o.o. | $275,638,188.29 | medi-more.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-07-23 | Share capital change (1,000,000.00 PLN → 21,000,000.00 PLN) | |
| 2018-03-27 | Name change ("pgf Urtica" → Urtica) | |
| 2002-05-20 | Entered in the register |
FAQ
Last updated: 2026-10-08